I now have sufficient content from the medical library and my own knowledge. Let me compile a comprehensive physiotherapy-focused UVR answer.
Ultraviolet Radiation (UVR) in Physiotherapy - Complete Notes
1. Introduction
Ultraviolet radiation (UVR) is a form of electromagnetic radiation lying just beyond the violet end of the visible spectrum, with wavelengths ranging from 100 to 400 nm. It sits between visible light and X-rays in the electromagnetic spectrum. In physiotherapy and dermatology, UVR has been used therapeutically for over a century, primarily for skin conditions, wound healing, and phototherapy.
The sun provides the primary natural source of UVR. Artificial sources include mercury vapour lamps, fluorescent lamps, cold quartz lamps, hot quartz lamps, and xenon arc lamps.
2. Classification of UVR (Wavelength Bands)
| Band | Wavelength | Characteristics |
|---|
| UVA (Long-wave UV) | 315-400 nm | Penetrates deepest - reaches dermis; causes immediate pigmentation darkening; photoaging; least erythrogenic; responsible for PUVA therapy |
| UVB (Medium-wave UV) | 280-315 nm | Main therapeutic band in physiotherapy; produces erythema; delayed tanning; stimulates vitamin D synthesis; causes DNA pyrimidine dimer formation |
| UVC (Short-wave UV) | 100-280 nm | Most bactericidal; absorbed by ozone layer - does NOT reach earth's surface naturally; used in germicidal lamps; not used therapeutically on deep tissue |
- Narrowband UVB (NB-UVB): 311 nm - this specific wavelength is the most therapeutically effective for psoriasis and other skin conditions
- Broadband UVB (BB-UVB): 280-315 nm full range
From Harrison's: "The outermost epidermal layer, the stratum corneum, is a major absorber of UV-B, and less than 10% of incident solar UV-B wavelengths penetrate from the epidermis to the dermis. Approximately 3% of radiation below 300 nm, 20% of radiation below 360 nm, and 33% of short visible radiation reach the basal cell layer in untanned human skin. UV-A readily penetrates to the dermis." - Harrison's Principles of Internal Medicine 22E
3. Physical Properties of UV Sources
Sources Used in Physiotherapy
| Source | Type | Output |
|---|
| Hot Quartz Lamp (Mercury vapour) | Broadband UVB + UVA | Main source for treatment; warm-up time ~5 min |
| Cold Quartz Lamp (Low pressure mercury vapour) | Mainly UVC (253.7 nm) | Used for bactericidal purposes; wound and cavity treatment |
| Fluorescent UV Lamps | UVA or UVB specific | Used in phototherapy cabinets |
| Kromayer Lamp | Quartz mercury lamp | Direct contact method; used in wound cavities |
4. Physiological Effects of UVR
A. Erythema (Redness)
- UVR causes vasodilation of superficial capillaries in the skin
- Results from release of histamine, prostaglandins, and other vasoactive substances
- Onset: UVB erythema peaks at 6-24 hours after exposure
- UVA erythema peaks at 4-8 hours and appears more rapidly but is less intense
B. Pigmentation (Tanning)
- Immediate pigment darkening (IPD): occurs within minutes of UVA exposure; represents oxidation of pre-existing melanin; fades within 20-30 minutes; provides no photoprotection
- Delayed tanning: visible within 24-72 hours after UVB and UVA; represents new melanin synthesis via increased tyrosinase activity; provides photoprotection
- Chronic UVR exposure increases melanocyte density up to 2x at sun-exposed vs. non-exposed sites
C. Epidermal Thickening (Hyperplasia)
- Repeated exposure stimulates keratinocyte proliferation
- Thickening of stratum spinosum and stratum corneum
- Increases photoprotection naturally
D. Vitamin D Synthesis
- UVB converts 7-dehydrocholesterol in skin to pre-vitamin D3
- This then isomerizes to vitamin D3 (cholecalciferol)
- UVA does not drive vitamin D synthesis
E. Bactericidal Effect
- Particularly UVC (253.7 nm) - damages bacterial DNA
- Used in wound treatment with cold quartz lamps
- Effective against MRSA and other pathogens on open wounds
F. Immunological Effects
- UVR depletes Langerhans cells from epidermis
- Impairs antigen presentation in skin-draining lymph nodes
- Expands regulatory T-cells (Treg) - key mechanism in treating psoriasis
- Shifts T-helper cell responses (Th1 -> Th2 shift)
G. Photochemical Effects
- UVB causes formation of cyclobutane pyrimidine dimers and 6,4-photoproducts between adjacent thymine/cytosine bases in DNA
- These are potentially mutagenic
- Relevant to both therapeutic and harmful effects
5. The Minimal Erythema Dose (MED)
The MED is the fundamental dosimetry unit in UVR physiotherapy.
Definition: The smallest dose of UVR that produces a minimal, just-perceptible erythema (redness) over the entire exposed area when read at 24 hours.
MED Grading / Classification of UVR Doses
This is the classic physiotherapy dosimetry classification:
| Grade | Dose | Clinical Reaction | Time to Appear | Duration |
|---|
| E1 (Sub-erythema dose / SED) | Below 1 MED | No visible erythema | - | - |
| E2 (Minimal erythema dose / MED) | 1 MED | Barely perceptible pinkish erythema | 6-8 hours | Fades within 24 hours |
| E3 (First degree / Suprathreshold) | 2-3 MED | Definite redness, slight oedema, mild tenderness | 4-6 hours | Persists 1-3 days |
| E4 (Second degree) | 5-6 MED | Severe erythema, oedema, tenderness, peeling/desquamation | 2-4 hours | Persists 5-7 days |
| E5 (Third degree) | >10 MED | Blistering, severe pain, systemic symptoms (fever, malaise) | 2 hours | Prolonged, tissue damage |
MED Testing Protocol (Standard)
- Expose 6 areas of 1 cm² on the inner forearm or lower back
- Give increasing doses of UV to each area
- NB-UVB: 200, 400, 600, 800, 1000, 1200 mJ/cm²
- BB-UVB: 20, 40, 60, 80, 100, 120 mJ/cm²
- Read at 24 hours
- MED = smallest dose producing uniform erythema over the entire exposed area
- Start treatment at 50-70% of MED
6. Therapeutic Uses in Physiotherapy / Dermatology
A. Psoriasis
- Narrowband UVB (NB-UVB, 311 nm) is first-line phototherapy
- NB-UVB: 2-5 treatments/week; dose increased by 10-20% per session
- Goeckerman regimen: UVB + tar application
- Long-term NB-UVB found to carry NO significantly increased skin cancer risk (unlike PUVA)
B. PUVA (Psoralen + UVA) Photochemotherapy
- Combines oral 8-methoxypsoralen (8-MOP) + UVA
- 8-MOP dose: 0.4-0.6 mg/kg taken 90 minutes before UVA exposure (dissolved form) or 0.6 mg/kg 120 minutes before (micronized form)
- UVA fluorescent lamps with emission peak at 352 nm (near psoralen absorption maximum)
- Treatment frequency: 2-4 times/week, NOT on consecutive days
- Used for: psoriasis, vitiligo, mycosis fungoides (cutaneous T-cell lymphoma), atopic dermatitis
- Minimum Phototoxic Dose (MPD) is used instead of MED; read at 72 hours
- Long-term PUVA carries dose-related risk of SCC (adjusted RR = 8.6 for 100-337 treatments)
C. Vitiligo
- Narrowband UVB or PUVA
- Stimulates melanocyte proliferation and migration from follicular reservoirs
D. Wound Healing
- UVC (cold quartz/Kromayer lamp) used for:
- Infected wounds and pressure sores
- Ulcers (venous, diabetic)
- Burns
- Sinuses and body cavities (using Kromayer with quartz rod)
- Bactericidal effect is primary mechanism
E. Atopic Dermatitis (Eczema)
- NB-UVB and UVA1 are effective
- UVA1 (340-400 nm) penetrates deeper than UVB; useful for lichenified/thickened eczema
F. UVA1 Phototherapy
- Wavelength: 340-400 nm; penetrates deeper into dermis than UVB
- Dosing regimens: Low dose (10-30 J/cm²), Medium dose (40-70 J/cm²), High dose (130 J/cm²)
- Start at 20-30 J/cm², increase to full dose within 3-5 treatments
- Frequency: 3-5 times/week
- Lower burn risk than UVB or PUVA
- Used for: morphea, localized scleroderma, atopic dermatitis
G. Other Indications
- Jaundice of the newborn (phototherapy)
- Mycosis fungoides
- Uremic pruritus
- Pityriasis rosea
- Lichen planus
7. Contraindications to UVR Therapy
Absolute Contraindications
- Xeroderma pigmentosum (defective DNA repair)
- Lupus erythematosus (photosensitive)
- Active tuberculosis of the skin
- History of melanoma
- Existing skin malignancy
- Porphyria
Relative Contraindications
- Previous extensive PUVA therapy (cumulative dose concern)
- Photosensitive conditions (certain drug ingestion - tetracyclines, thiazides, phenothiazines)
- Recent radiotherapy to skin
- Basal cell naevus syndrome
- Very fair (Type I) skin with history of multiple sunburns
- Pregnancy (relative)
8. Precautions and Safety
- Eye protection: UV-opaque goggles must be worn by BOTH patient and therapist
- Genitalia shielded unless being treated
- Sunscreen may be applied to normal skin areas adjacent to treated zones
- Gradual dose increments prevent burns
- A burn reported by the patient at the next visit (even if no longer visible) must be managed as still-visible
Dose Adjustment After Missed Treatments (Fitzpatrick protocol)
| Duration of Missed Treatment | Dose Adjustment |
|---|
| Less than 1 week | No change |
| 1-2 weeks | Decrease by 50% (BB-UVB) or 25% (NB-UVB/PUVA) |
| 2-3 weeks | Decrease by 75% (BB-UVB) or 50% (NB-UVB/PUVA) |
| More than 3 weeks | Restart at initial dose |
9. Adverse Effects
Short-term
- Erythema, burning, pain
- Blistering (severe burns)
- Photokeratitis (UV burns to cornea - "arc eye") - prevented by goggles
- Systemic toxicity with large area burns (fever, malaise)
- PUVA: nausea from psoralen (take with food)
Long-term
- Photoaging: premature skin aging, wrinkling, solar elastosis (primarily UVA)
- Non-melanoma skin cancer (NMSC): dose-related; PUVA carries SCC risk (RR 8.6 at high cumulative dose); chronic UVB also carries risk
- Melanoma risk: slight increased risk with prolonged PUVA
- Cataract formation: without adequate eye protection
- Immunosuppression: persistent reduction in skin immune surveillance
10. Skin Phototypes (Fitzpatrick Classification)
Determines initial UVR dosing when MED is not tested:
| Phototype | Description | UVR Reaction |
|---|
| I | Very fair, freckles, red/blonde hair | Always burns, never tans |
| II | Fair skin, blue/green eyes | Usually burns, tans minimally |
| III | Medium skin | Sometimes burns, tans gradually |
| IV | Olive/light brown skin | Rarely burns, tans easily |
| V | Brown skin | Very rarely burns, tans deeply |
| VI | Dark brown/black skin | Never burns, deeply pigmented |
Initial NB-UVB doses by phototype range from 130 mJ/cm² (Type I) to 400 mJ/cm² (Type VI), with maximum doses from 2000 to 5000 mJ/cm² respectively.
Sources:
- Fitzpatrick's Dermatology - Phototherapy chapter (Broadband/Narrowband UVB and PUVA protocols)
- Harrison's Principles of Internal Medicine 22E - UV Radiation and Skin Structure and Function
- Dermatology 2-Volume Set 5e - UVR and Melanogenesis